• 1
    Stevenson D, Sanchez-Borges M, Szczekilik A. Classification of allergic and pseudo-allergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol 2001; 87:14.
  • 2
    Jenkins CH, Costello J, Hodge L. Systematic review of prevalence of aspirin- induced asthma and its implications for clinical practice. BMJ 2004; 328:43440.
  • 3
    Jenneck C, Juergens U, Buecheler M, Novak N. Pathogenesis, diagnosis and treatment of aspirin intolerance. Allergy Asthma Immonol 2007; 99:1321.
  • 4
    Kim JE, Kountakis SE. The prevalence of Samter's triad in patients undergoing functional endoscopic sinus surgery. Ear Nose Throat J 2007; 86:3969.
  • 5
    Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. AIANE investigators European Network on aspirin induced asthma. Eur Resp J 2000; 16:4326.
  • 6
    Kowalski ML, Makowaska JS, Blanca M, Bavbek S, Bocheneck G, Bousquet J, et al. Hypersensitivity to NSAIDs-classification, diagnosis and management: review of the EAACI/ENDA and Ga2len/Hanna. Allergy 2011; 66:81829.
  • 7
    Viola M, Rumi G, Valuzzi RL, Gaeta F, Caruso C, Romano A. Assessing potential determinants of positive provocation tests with NSAID hypersensititvity. Clin Exp Allergy 2010; 41:96103.
  • 8
    Sánchez-Borges M. NSAID hypersensitivity (respiratory, cutaneous, and generalized anaphylactic symptoms). Med Clin North Am 2010; 94:85364, xiii.
  • 9
    Hecksteden K, Schafer D, Stuck BA, Klimek L, Hormann K. Diagnosis of analgesic intolerance using a functional cell test (“analgesic intolerance test”: AIT). Allergologie 2003; 26:26371.
  • 10
    Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 2007; 62:11118.
  • 11
    Barranco P, Bobolea I, Larco JL, Prior N, Lopez-Serrano MC, Quirche S. Diagnosis of aspirin induced asthma combining the bronchial and the oral challenge tests: a pilot study. J Investig Allergol Clin Immunol 2009; 19:44652.
  • 12
    Milewski M, Mastalerz L, Nizankowska E, Szczeklik A. Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. J Allergy Clin Immunol 1998; 101:5816.
  • 13
    Stevenson DD, Simon RA, Mathison DA, Christiansen SC. Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics. Ann Allergy Asthma Immunol 2000; 85:47782.
  • 14
    Nathan RA, Eccles R, Howarth PH, Steinsvag SK, Togias A. Objective monitoring of nasal patency and nasal physiology in rhinitis. J Allergy Clin Immunol 2005; 115:S44259.
  • 15
    Lund VJ, Kennedy DW. Staging for rhinosinusitis. Otol H & N Surg 1997; 117:S3540.
  • 16
    Malm L, Gerth van Wijk R, Bachert C. Guidelines for nasal provocations with aspects on nasal patency, airflow, and airflow resistance. Rhinology 2000; 38:16.
  • 17
    Holmström M, Scadding GK, Lund VJ, Darby YC. Assessment of nasal obstruction. A comparison between rhinomanometry and nasal inspiratory peak flow. Rhinology 1990; 28:1916.
  • 18
    Farhat DVN, Theodoratou E, Farrington SM, Tenesa A, et al. Effect of aspirin and NSAIDs on risk and survival from colorectal cancer. Gut 2010; 59:16709.
  • 19
    Cuzick J, Otto F, Baron JA, Brown PH, et al. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol 10; 2009: 5017.
  • 20
    Mita H, Higashi N, Tamiguchi M, Higashi A. Increased urinary leukotriene B4 glucuronide concentration in patients with aspirin intolerant asthma after intravenous aspirin challenge. Clin Exp Allergy 2004; 34:12629.